Biotech entity
Of the tracked stories, 1 of 2 also mention Brigham and Women's Hospital, the most common co-covered peer. clinical-trial accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. COSMOS Trial appears in 2 tracked Biotech stories from March 9, 2026.
Last mentioned: Mar 9, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention Brigham and Women's Hospital, the most common co-covered peer. clinical-trial accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. COSMOS Trial appears in 2 tracked Biotech stories from March 9, 2026. The tracked stories average 29.5 original sources each.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering COSMOS Trial. Shared-story counts are live from our verified record — not editorial picks.
Biological Aging Analysis
New data reveals daily multivitamins significantly slow epigenetic aging clocks.
Biological Aging Data
New analysis links multivitamin use to slower epigenetic aging markers.
COSMOS-Clinic Update
In-person clinical assessments reinforce cognitive aging slowing by 3 years.
COSMOS-Web Study
Large-scale web-based study confirms memory benefits of daily supplements.
COSMOS-Mind Results
Initial findings show multivitamins improve cognition in older adults.
Cognitive & Clinical Results
Initial findings on memory and cardiovascular outcomes published with mixed results.
COSMOS Trial Launch
Large-scale randomized trial begins investigating cocoa extract and multivitamins.
A significant new clinical study indicates that daily multivitamin supplementation may slow biological aging in older adults by approximately two years. The findings suggest that consistent micronutrient intake supports cellular health and mitigates the epigenetic markers associated with age-related decline.
A prespecified analysis of the large-scale COSMOS trial has found that daily multivitamin-multimineral supplementation significantly slows markers of biological aging in older adults. The study provides robust clinical evidence that standard nutritional interventions can influence cellular longevity and epigenetic health beyond simple deficiency prevention.
COSMOS Trial is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
